Introduction
In ulcers' healing the organic contaminations causes a problem that are not scrupulously removed by patients or medical personnel, particularly, where approximately 90 % patients suffering from the disease have been cured in an open system care. Secondly, up to the latest days there was no appropriate medicine effectively supporting wound's cleaning. Necrotic organic substances remaining in the wound do activate a holder's immunological system and promote bacteria, fungi, and virus increments, in which environment reactive oxygen species are created. These very aggressive substances destroy healthy tissues and favour accumulating significantly extensive amount of granulocytes which, in turn, affect microobstructions and micro-clots in the wound's edge area. The mentioned circumstances suspend the healing or even preclude this process. Another issue is, that majority of patients do not rinse up the whole wound surface while the edges only or they do not change bandages sufficiently often. A commonly used salt to rinse the wound is a physiological salt or Ringer's liquid. However, these are the liquids which do not contain a conservation mean. Therefore, outstaying usually in an open way for many days, or more often in a room temperature, the solutions can be secondarily contaminated. What is more, patients often use a tap water which is also bacterially contaminated. Having in mind a nature of the wound's protein components, which are strongly associated with a substratum via fibrins, it is not indifferent what the wound is rinse up with (1, 2, 3, 4) .
In the study, the Authors present a new tactics against lasting wounds. It relies on supplementing the TIME procedure by the Lav acronym which means lavage (washing, cleaning) in the first instance, before wound treatment. Moreover, an effectiveness of wound cleaning from the organic elements including bacteria using a physiological salt (NaCl) and Prontosan (polyhexanide+betaine) has been reported (5, 6) . 
Material and method
In the study have been enrolled 60 patients (19 males and 41 females, 47-83 of age with 58.5 average). Retired persons (52 patients) were predominant in the group, widowers (43), alone (39) and inhabitants of a >100 thou. population city (38). All the patients have been suffering from thrombosis for 2-15 years. In the color duplex Doppler's test in all the patients signs of p o s t t h r o m b o t i c s y n d r o m e w i t h d a m a g e o f v e n o u s v a l v e s o n d i f f e r e n t l e v e l s o f t h e extremity has been diagnosed. A valve damage in femoral vein was predominant in 49 patients (formerly treated but unsuccessfully). In the study 30 patients were taken into account with 44 ulcers' histories (158 visit records). From the preliminary set of 60 patients, those were excluded who appeared once or who did not restrict the regimes of the treatment procedure. After decoding the bottles' containments and appropriate patients' assigning to the groups, it was established that 17 patients were treated by Prontosan, whereas 13 by the 0.9% NaCl solution, respectively.
Drop out patients are presented in table 2.
Prontosan group 0.9% NaCl group Total  Adverse events  3  2  5  Major protocol violation  2  4  6  Patient wished to leave study  3  5  8  Patient not compliant  4  3  7  Significant concomitant illness  1  3  4  Treatment failure  0  0  0  Total  13  17  30   Table 2 .
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Study design
This study was an open, multicenter, prospective, randomized, double blind, parallel group study on efficacy of Prontosan solution in treatment of venous leg ulcers.
The study was performed in 3 centers and was included a total number of 60 patients. After dropped out 30 patients because of different reasons remaining patients were as follow : 17 patients for Prontosan and 13 for 0.9% NaCl subgroup. Treated venous leg ulcers were classified according to ABI /Ankle-Brachial Index/. The venous leg ulcers were recognized when ABI was higher than or equal to 0,9 and no lymphatic disorders revealed.
All study participants had been treated during 12 weeks or until complete healing is achieved (whichever occurs first).
Study population
The study population consists of individuals above 18 years of age, in which venous leg ulcers have been identified of the size limited by the size of applied wound dressing and ABI ≥ 0.9.
Exclusion criteria were as follows:
a. hypersensitivity to any of Prontosan® components or to any of wound dressing components, b. active osteomyelitis in the area of the treated ulcer, c. active rheumatoidal or collagen disease of blood vessels treated with corticosteroids, d. neoplastic disease e. serum proteins < 4 g/dl f. anemia: < 10g haemoglobin per dl g. exclusion of phlebotropic, vasorelaxing and reological medicines for the study period h. diabetic foot i. lack of compliance of the patient j.
intolerance to compression therapy
Route of administration
External application.
Dosage regimen
Either Prontosan® or saline solution (depending on the study group) had been applied at every change of the wound dressing. Frequency of dressing change: every day.
Application
1. first, Prontosan/saline solution was used for cleansing of the wound bed; this will be done using sterile gauze & sterile gauze compress soaked in the solution an used to cover the wound for 15 min, then removed from the wound bed 2. next, the polyurethane wound dressing was activated with given solution and used to cover the wound 3. finally, medical compression stockings was used to fasten the wound dressing to the patient's leg.
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Prontosan or 0.9% NaCl solution were used to soak and gently remove the wound dressing at the time of each dressing change procedure.
For each patient 10 bottles 350 ml of Prontosan or 0.9% NaCl saline solution were available and used as necessary according to applied randomization scheme.
Efficacy criteria
Primary efficacy criteria:
1. incidence of infection during treatment period 2. rate of healing of the ulcer in cm 2 /week Secondary efficacy criteria:
1. complete healing of the ulcer -ulcer is defined as completely healed if there is stable wound epithelialization 2. improved state of the ulcer -ulcer is defined as improved if there is decrease in its surface of at least 25% in comparison to the initial findings 3. lack of improvement of the ulcer -defined as the ulcer that do not belong to any of the above listed categories Tertiary efficacy criteria:
1. incidence of pain during dressing change, comfort for the patient -subjective pain scale used during the course of study -before, during and after each dressing change (CIVIQ questionnaire) 2. incidence of side effects 3. change of clinical symptoms of the ulcer (granulation, epithelialization; computer-aided analysis of digital pictures of the wound).
Methods of evaluation of the efficacy of treatment include:
planimetry of the ulcer, software-aided surface evaluation, -assessment of clinical status of the ulcer (computer-aided analysis of pictures of wound surface) -assessment of changes in microbial load in the ulcer in first, second & last visit of the study -photographic documentation of the treatment (done in a standardized way to allow for further computer-aided analysis) -laboratory tests: full blood count, total proteins
Safety evaluation
Assessment of differences between measured general health parameters (as listed under laboratory tests) as well as incidence of adverse reactions before and after therapeutical process.
Following the study qualification during the initial visit (D-0), for bacteria culture inoculation, swabs from the wounds were taken and bottles with unknown liquid together with the treatment prescription among the patients were distributed. During the control visits before bandaging a digital photographical documentation of healing was conducted.
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The treatment procedure consisted with:
Every day applying wet gauze with the liquid from the bottle. The dressing was on the wound during fifteen minutes than polyurethan wound dressing ( Allevyn ) was put on. Such dressing was covered by two knee stockings. First was a thrombo profilactic and the second one was Sigvaris 503 class compression. Day by day patient change the dressings according to above mentioned method. To make easier for the patients each one get diary with detail prescription how to use getting materials for the treatment.
The visits' D-13 and D-31, D-58 consisted with: check the wound healing process, make a digital photography, take the culture from the wound bed, put the new dressing on, take used bottles off and give new bottles with the medicament.
The last visit was D-85. During this visit physician estimated the healing process, advers events and ask patients about their satisfaction with the treatment.
Statistical analysis
In the statistical analysis, hierarchical (multi-level) modelling has been performed that allows variance in outcome variable (wound surface) to be analysed at multiple hierarchical levels (i. 
Results
In the group of patients underwent study were 11 smokers but only two smokers belongs to the group of assessed patients, one in group of Prontosan and one in 0.9% NaCl group.
The ulcer location was predominantly in ankle region (49 ), above ankle ( 11) . Status of the wound before and following treatment are presented in Table 3 .
Total healing rate in the estimated groups is presented in table 4 Prontosan n = 17 0.9% NaCl n = 13 Total healing of ulcer within 90 days 16 6 85% of ulcer healing 1 3 50% of ulcer healing 0 3 30% of ulcer healing 0 1 Lack of improvement of the ulcer 0 0 Table 4 .
All blood and urine tests were in of normal range before and following study procedure.
Only in three patients of Prontosan group appeared adverse events listed in NaCl 91 21 419,8 ***** ******* ***************** ***************** ********** The regression estimates of the assumed hierarchical model are reported in Table 6 Prontosan patients represented a larger reduction of the wound surface during treatment compared to NaCl patients (86 mm 2 in average) , however, the difference was not statistically significant (groupProntosan);  A statistically significant difference in healing effect in time between the treatment groups was observed and for each therapy increment of one day, the reduction of 5 mm 2 was larger approximately in Prontosan patients compared to NaCl group (time:groupProntosan).
The graphical model of the reduction of ulcers in treatment groups is presented in Figure 3 . The t-test estimates provide evidence of the over twice as high ulcer reduction in Prontosan treatment patients compared to NaCl group. The average healing in Prontosan patients exceeded 13 mm 2 per day whereas in NaCl patients it was much below 6 mm 2 daily. The difference in means is statistically significant. The results provide evidence of significantly lower infection numbers in Prontosan patients' ulcers in comparison to the NaCl group (nearly twice as low).
Discussion
In the study 30 patients were taken into account with 44 ulcers' histories (158 visit records).
From the preliminary set of 60 patients, those were excluded who appeared once or who did not restrict the regimes of the treatment procedure. After decoding the bottles' containments and appropriate patients' assigning to the groups, it was established that 17 patients were treated by Prontosan, whereas 13 by the NaCl solution, respectively.
The obtained outcomes provide evidence nearly three times as a higher healing speed in those patients who were treated by Prontosan in comparison to the NaCl group. The cleaning from bacteria tribes was as twice as higher, respectively. In both the analyses the results were statistically significant.
The importance of lavasepsis for the treatment of chronic wounds results from a fundamental, commonly understood and accepted standard, which for wound management field translates as follows: "first wound hygiene, then wound tratment (7) ." This principle goes hand in hand with the generally accepted rule of limiting the use of drugs to an essential minimum and giving prophylaxis priority in medicine. What is then the real impact of lavasepsis on the individual elements of the TIME framework?
The effect of lavasepsis on Tissue management is many-sided. It softens and separates necroses from healthy tissue, which facilitates their identification and elimination. Furthermore, lavasepsis removes crust, scabs and exudate residues, as well as fibrin coatings from the wound surface (8, 9) . Finally, everyday wound lavasepsis secures effective biofilm removal (10) . Wound lavasepsis cannot replace surgical interventions or sharp debridement, but it can considerably help in assessment of the wound and in effective employment of the required procedure.
In the area of Inflammation and infection control, it is worth emphasising the significance of the aforementioned cleansing properties, namely the removal of wound coatings and biofilm from the wound surface. The use of antiseptics and antibiotics for a wound that is either contaminated or coated with a biofilm is inadequate. It can cause the therapy to be ineffective and increases the likelihood of the development of drug-resistance (12, 14) . Wound cleansing or hygiene lowers the microbial load and significantly lowers the risk of complications, including infections. The microcirculation, oxygen and nutrient availability, as well as the effectiveness of patient's immune system are improving. Lavasepsis cannot replace antisepsis, but secures optimal conditions for the use of local and systemic antiinfectives. In this way, it minimizes and streamlines their application.
Maintaining an adequate Moisture balance of the wound is an important element of the therapeutic process. Everyday wound lavasepsis helps to remove excessive exudate (also by reinforcing the habit of wound cleansing). It facilitates wound moistening in the case of dry wounds and raises the effectiveness of wound dressings. Lavasepsis is not meant to replace modern wound dressings, which are essential for maintaining a moist wound environment and absorbing excessive exudate. It can, however, prepare the wound bed in a way that ensures optimal therapeutic effect of their application.
Epithelial/edge advancement is an element of the TIME framework, for which lavasepsis is important because of the fact that the removal of wound coatings facilitates the reestablishment of cellular proliferation and angiogenesis. Lavasepsis also removes potential physical barriers to epithelial growth across the wound bed. Finally, optimal wound bed preparation is a prerequisite for effective use of advanced therapies, such as skin transplants and cellular growth factors (11) .
Lavasepsis thus has a significant influence on all elements of the TIME framework, being a process of preparing the wound bed per se. Thanks to this, it allows one to achieve optimal results from any therapeutic procedures applied at specific stages of wound treatment.
The above outcomes point to the conclusion that a lack of effective wound cleaning from organic elements laying on the wound bed as well as from the remained bacteria (protected by the bacterial biofilm which is difficult to remove using physiological salts) result in significant elongation of the healing time. Prontosan dissolves and removes contaminations from the wound bed, destroys the bacterial biofilm and accelerates the healing of ulcers. Despite of a slightly higher price, the use of Prontosan may importantly reduce sufferance in patients likewise both the costs carried out by their own and the governmental subsidies, taking the time of the medical treatment in mind. Further economical simulation are required to estimate such the profits. Our results were confirmed by other investigators (12) .
Lavasepsis is a new term created to describe and delineate a group of products that, according to the authors, brings in a new, desired quality to local treatment of chronic wounds (13) . This new quality arises directly from the evolution of the WBP paradigm and TIME framework set earlier by EWMA experts (14) . The TIME framework and EWMA recommendations are a good milestone not only for clinical practice, but also for manufacturers who are trying to adopt their product offering to the needs of contemporary medicine. The LAV-TIME concept presented in this paper, extends and supplements the www.intechopen.com LavTIME -a Brand-New Treatment Method of Lasting Wounds -A Multi-Centre Randomized Double-Blind Study on Effectiveness of Polyhexanide...
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TIME framework with the new and important element of lavasepsis (15, 16, 17, 18) . Although at present there are few products on the market that can be described as "lavaseptics", the rapid development of this group of products is to be expected, and their availability on the medical market will grow. This would certainly be of benefit to the medical world, and most of all to the patients (19, 20) .
Conclusion
1. A statistically significant difference in healing effect in time between the treatment groups was observed and for each therapy increment of one day, the reduction of 5 mm 2 was larger approximately in Prontosan patients compared to NaCl group. 2. The results provide evidence of significantly lower infection numbers in Prontosan patients' ulcers in comparison to the NaCl group. 3. Prontosan appeared as a very good tolerated product for patients without any serious adverse effects. Only three out of seventeen patients have a temporary local problems with Itching ( two patients ) and eruption of the skin ( one patient ). 4. 16 patients out of 17 in the Prontosan group were totally healed within 90 days of treatment and only 6 out of 13 were totally healed in NaCl group at the same time.
